MiNK (INKT) Director Brian Corvese Receives 1,633 RSUs

What Happened

• Brian Corvese, a director of MiNK Therapeutics, was granted 1,633 restricted stock units (RSUs) on 2026-09-01. The grant is reported at $10.95 per share, with a total reported value of $17,881. This was an award of RSUs received in lieu of cash board and committee retainers, not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-09-01; 1,633 RSUs at $10.95 per share (total $17,881).
• Transaction type/code: Award/Grant (A) — RSU grant (derivative award that converts to shares at vesting).
• Vesting and conditions: RSUs will vest one month from the grant date (per filing footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeline: Form 4 filed 2026-09-02 for the 2026-09-01 grant — appears timely (Form 4 due within two business days).

Context

• RSUs are a form of compensation that represent the contingent right to receive one share per RSU upon vesting; they are commonly used for director pay and do not necessarily signal the director buying or selling stock. This award converts to shares only after the stated vesting date.